Login

CEO Spotlight: MeridianLink CEO Nicolaas Vlok shares what excites him most about joining the #NYSECommunity now that his company is public. 00:10:00

Share On Facebook Share On Twitter

Nicolaas Vlok | CEO - MeridianLink, Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Pegasystems, led by CEO Alan Trefler, has been making significant strides since transitioning to cloud services.|Alan Trefler is the Founder and CEO of Pegasystems Inc.,
00:10:00
Rising Student Loan Interest Rates: What Borrowers Need to Know with Jessica DeBold | Jessica DeBold, Certified Financial Planner, Goldstone Financial Group
00:10:00
Mutual Fund Dating: The Ultimate Guide to Choosing the Right Investment Partner | Ian draws , Founder , Open World Financial Life Planning.
00:10:00
currently manages approximately $1.3 billion in assets within its hedge fund portfolios|Paul Ernst, Managing Director,Sandler Capital Management
00:10:00
Strategic Growth in European Real Estate: Insights from Rory Buck of Clarion Partners Europe | Managing Partner, Clarion Partners Europe
00:10:00
Investor Insights: Real Estate, Infrastructure, and Renewable Trends | Bruce Flatt, CEO,Brookfield Asset Management.
00:10:00
The Power of Compounding: A Journey of 25 Years in Mutual Funds | Nilesh Shah, CEO , Kotak Mutual Fund .
00:10:00
Breaking Through the Acquisition Barrier in Consumer, Gaming, and Marketplace Industries|Ben Mathews,General Partner, Night Ventures
00:10:00
Invests in talented founders building the next generation of software giants|Mark Mullen,Co-Founder and General Partner,Bonfire Ventures
00:10:00
Exploración Minera en San Juan: Oportunidades y Desafíos
00:10:00
Blue Value Advisors: Your Guide from Business Assessment to Successful Exit
00:10:00
Financial Analysis of ContourGlobal: A Deep Dive into Their Profit Margins and Earnings

© 2017 - Neuhu+